Article

Evaluating Implementation of NCCN Guideline-Directed Genetic Screening Recommendations for Patients with Pancreatic Ductal Adenocarcinoma

2023-07-27

Abstract excerpt

<h4>Purpose: </h4> In 2019, the National Comprehensive Cancer Network (NCCN) recommended genetic testing for all patients with pancreatic ductal adenocarcinoma (PDAC). To evaluate the status of implementation of these guidelines in a loco-regional setting, we performed a retrospective, observational study among patients with newly diagnosed PDAC who received oncologic care at Northeast Georgia Medical Center in Ge...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 56e26f4a-1220-5b4a-b410-6142176473b0
DOI: 10.21203/rs.3.rs-3179755/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evaluating Implementation of NCCN Guideline-Directed Genetic Screening Recommendations for Patients with Pancreatic Ductal AdenocarcinomaDOI 10.21203/rs.3.rs-3179755/v1Read

Hereditary Cancer Clinics Improve Adherence to NCCN Germline Testing Guidelines for Pancreatic Cancer.Semantic proximity Read

Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center Oncology Clinic.Semantic proximity Read

Germline genetic testing among patients with pancreatic adenocarcinoma: A Pancreatic Cancer Action Network patient survey.Semantic proximity Read

Implementing Systematic Genetic Counseling and Multigene Germline Testing for Individuals With Pancreatic Cancer.Semantic proximity Read

Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic AdenocarcinomaSemantic proximity Read

Development of a Novel Protocol for Germline Testing in Pancreatic Cancer.Semantic proximity Read

Expanding access to genetic testing for pancreatic cancer.Semantic proximity Read

Socioeconomic and Demographic Barriers Associated with Delays in Pancreatic Cancer Germline Genetic TestingSemantic proximity Read

Oncology clinic-based germline genetic testing for exocrine pancreatic cancer enables timely return of results and unveils low uptake of cascade testing.Semantic proximity Read

Adherence to NCCN Genetic Testing Guidelines in Pancreatic Cancer and Impact on Treatment.Semantic proximity Read

Clinical Significance of MTAP Deletion in Pancreatic Ductal Adenocarcinoma: A Real-World US Patient Cohort StudySemantic proximity Read

Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017.Semantic proximity Read